Journals / The Anatolian Journal of Cardiology / 2022 / Cilt: 26 - Sayı: 4

Reply to Letter to the Editor: “Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity?”

Pages
344–344
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

DİNDAŞ, F., GÜNGÖR, H., EKİCİ, M., AKOKAY, P., ERHAN, F., DOĞDUŞ, M., YILMAZ, M. B. (2022). Reply to Letter to the Editor: “Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity?”. The Anatolian Journal of Cardiology, Cilt: 26 - Sayı: 4, 344–344. https://ajindex.com/articles/407423

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Ergür BU, Çilaker Mıcılı S, Yılmaz O, Akokay P. The effects of α-lipoic acid on aortic injury and hypertension in the rat remnant kidney (5/6 nephrectomy) model. Anatol J Cardiol. 2015
  2. 15(6):443-449. [CrossRef] 2. Wouters KA, Kremer LC, Miller TL, Herman EH, Lipshultz SE. Protecting against anthra- cycline-induced myocardial damage: a review of the most promising strategies. Br J Haematol. 2005
  3. 131(5):561-578. [CrossRef] 3. Yang SC, Chuang MH, Li DK. The development of congestive heart failure and ventricu- lar tachycardia after first exposure to idarubicin in a patient with acute myeloid leukae- mia. Br J Clin Pharmacol. 2010
  4. 69(2):209-211. [CrossRef] 4. Zidan A, Sherief LM, El-Sheikh A, et al. NT-proBNP as early marker of subclinical late cardiotoxicity after doxorubicin therapy and mediastinal irradiation in childhood cancer survivors. Dis Markers. 2015
  5. 513219. [CrossRef] 5. Sims M. The Role of TRAIL-Signalling in Doxorubicin-Induced Cardiotoxicity [Disserta- tion]. The University of Adelaide. 2020.